Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Operating Income: 2020-2023

Historic Operating Income for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to -$58.4 million.

  • Immuneering's Operating Income fell 16.57% to -$16.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$58.4 million, marking a year-over-year decrease of 12.89%. This contributed to the annual value of -$58.4 million for FY2023, which is 12.89% down from last year.
  • According to the latest figures from FY2023, Immuneering's Operating Income is -$58.4 million, which was down 12.89% from -$51.7 million recorded in FY2022.
  • In the past 5 years, Immuneering's Operating Income ranged from a high of -$17.1 million in FY2020 and a low of -$58.4 million during FY2023.
  • In the last 3 years, Immuneering's Operating Income had a median value of -$51.7 million in 2022 and averaged -$48.0 million.
  • Data for Immuneering's Operating Income shows a maximum YoY slumped of 98.37% (in 2021) over the last 5 years.
  • Immuneering's Operating Income (Yearly) stood at -$17.1 million in 2020, then plummeted by 98.37% to -$33.9 million in 2021, then crashed by 52.70% to -$51.7 million in 2022, then decreased by 12.89% to -$58.4 million in 2023.